Source | Match | ReputationScore* |
---|---|---|
NICAM: Nilotinib treatment for c-KIT mutated advanced AMM
Collection of samples and data across the following diseases: Malignant melanoma of eye (disorder). Phase II single arm study evaluating the activity of nilotinib in rare c-KIT mutated acral and mucosal melanoma (AMM). Entry into the trial is a 2 ste
...
|
|
*ReputationScore indicates how established a given datasource is. Find out more.